Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.36 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 2/20 | 0.35 |
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 2/20 | 0.32 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7746494 | 0.95 | MAPT (0.39) | LMNATP53TBXA2RMAPTDRD2 | |
| SCHEMBL7746035 | 0.91 | AGTR1 (0.36) | AGTR1AGTR2CNR2TBXA2R | |
| SCHEMBL7745380 | 0.88 | TBXA2R (0.39) | AGTR1AGTR2TBXA2R | |
| SCHEMBL7741627 | 0.87 | CNR2 (0.38) | AGTR1AGTR2CNR2IDH1TBXA2R | |
| SCHEMBL7745715 | 0.85 | AGTR1 (0.35) | AGTR1AGTR2CNR2IDH1TBXA2R | |
| SCHEMBL7741615 | 0.82 | CNR2 (0.42) | CNR2IDH1TBXA2RKDM4E | |
| SCHEMBL7741250 | 0.81 | AGTR1 (0.36) | AGTR1AGTR2LMNATP53CNR2 | |
| SCHEMBL7745710 | 0.81 | AGTR1 (0.38) | AGTR1AGTR2TP53IDH1TBXA2R | |
| SCHEMBL7745955 | 0.75 | TBXA2R (0.41) | TBXA2R | |
| SCHEMBL7746032 | 0.74 | FFAR4 (0.39) | LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |